Raymond James Financial
APYX icon

Raymond James Financial’s Apyx Medical APYX Stock Holding History

Raymond James Financial’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-83,809
Closed -$189K – 5052
2025
Q2 		$189K Sell
83,809
-800
-0.9% -$1.13K ﹤0.01% 4545
2025
Q1 		$116K Hold
84,609
– – ﹤0.01% 4525
2024
Q4 		$134K Buy
+84,609
New +$118K ﹤0.01% 4483

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's APYX Position: Q3 2025 in Review

Raymond James Financial sold out of Apyx Medical (APYX) in Q3 2025, closing a stake of 83,809 shares — an estimated $189K sold.

Raymond James Financial first reported a position in APYX in Q4 2024 and held it in 3 quarters. The position peaked at $189K in Q2 2025. 47 funds tracked by Wall St. Rank hold APYX as of Q3 2025.

  • Raymond James Financial reported no remaining Apyx Medical position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 83,809 Apyx Medical shares in Q3 2025, an estimated $189K.
  • Raymond James Financial first reported a position in Apyx Medical in Q4 2024 and held it in 3 quarters.
  • Raymond James Financial's Apyx Medical position peaked at $189K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.